Jardiance
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Jardiance in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Jardiance.
13
Global Revenue Ranking
Recent articles on PMLiVE featuring Jardiance
New negotiated prices are set to be announced by 1 September 2024 and implemented in 2026
The evolved brand includes the company’s first-ever brand claim, Life Forward
Approximately 7.2 million people in the UK are affected by the long-term kidney condition
The action comes after the first drugs subject to pricing negotiations were announced
The IRA programme is facing court challenges from leading drugmakers and industry groups
Non-small cell lung cancer accounts for up to 85% of all lung cancer cases in the US
Approximately 47 million people in the EU are affected by the long-term kidney condition
The incidence of type 2 diabetes in children has nearly doubled over the past two decades
Jardiance reduced disease progression and cardiovascular death by 28%
Revenues in the third quarter of 2021 were driven by volume growth in new medicines, but earnings per share were a fraction below analysts’ predictions
Results presented at the European Society of Cardiology Congress from the phase 3 trial demonstrated a 27% drop in hospitalisation risk
FDA recently removed emergency authorisation for bamlanivimab monotherapy
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology